| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.058 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |